1. Home
  2. BSX vs APH Comparison

BSX vs APH Comparison

Compare BSX & APH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • APH
  • Stock Information
  • Founded
  • BSX 1979
  • APH 1932
  • Country
  • BSX United States
  • APH United States
  • Employees
  • BSX N/A
  • APH N/A
  • Industry
  • BSX Medical/Dental Instruments
  • APH Electrical Products
  • Sector
  • BSX Health Care
  • APH Technology
  • Exchange
  • BSX Nasdaq
  • APH Nasdaq
  • Market Cap
  • BSX 146.2B
  • APH 167.3B
  • IPO Year
  • BSX 1992
  • APH 1991
  • Fundamental
  • Price
  • BSX $99.78
  • APH $138.19
  • Analyst Decision
  • BSX Strong Buy
  • APH Strong Buy
  • Analyst Count
  • BSX 19
  • APH 11
  • Target Price
  • BSX $124.53
  • APH $140.64
  • AVG Volume (30 Days)
  • BSX 8.0M
  • APH 8.7M
  • Earning Date
  • BSX 10-22-2025
  • APH 10-22-2025
  • Dividend Yield
  • BSX N/A
  • APH 0.72%
  • EPS Growth
  • BSX 54.68
  • APH 72.40
  • EPS
  • BSX 1.87
  • APH 3.00
  • Revenue
  • BSX $19,349,000,000.00
  • APH $20,973,500,000.00
  • Revenue This Year
  • BSX $21.04
  • APH $51.01
  • Revenue Next Year
  • BSX $11.45
  • APH $18.43
  • P/E Ratio
  • BSX $53.49
  • APH $46.36
  • Revenue Growth
  • BSX 21.61
  • APH 47.36
  • 52 Week Low
  • BSX $85.98
  • APH $56.45
  • 52 Week High
  • BSX $109.50
  • APH $142.50
  • Technical
  • Relative Strength Index (RSI)
  • BSX 50.50
  • APH 62.36
  • Support Level
  • BSX $97.45
  • APH $135.86
  • Resistance Level
  • BSX $102.27
  • APH $141.05
  • Average True Range (ATR)
  • BSX 1.85
  • APH 4.21
  • MACD
  • BSX -0.11
  • APH -0.05
  • Stochastic Oscillator
  • BSX 28.98
  • APH 75.59

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About APH Amphenol Corporation

Amphenol is a global supplier of connectors, sensors, and interconnect systems. It holds the second-largest connector market share globally and sells into the automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks end markets. Amphenol is diversified geographically, with operations in 40 countries.

Share on Social Networks: